Intercept Pharmaceuticals | ICPT - EPS Earnings Per Share


Intercept Pharmaceuticals reported $0.08 in EPS Earnings Per Share for its fiscal quarter ending in September of 2023.



Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amarin USD 0.14 0.06 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
Arrowhead Research USD 0.22 0.33 Dec/2025
AstraZeneca USD 2.12 0.26 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Galectin Therapeutics USD -0.2 0.01 Jun/2024
Gilead Sciences USD 1.86 0.61 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Incyte USD 1.8 0.46 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Novartis USD 1.54 0.5 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025